| 1 |
35574563 | A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia. | 2022 |
1 |
| 2 |
34988458 | Sodium selenate as a disease-modifying treatment for mild-moderate Alzheimer's disease: an open-label extension study. | 2021 |
1 |
| 3 |
33199422 | A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. | 2020 Nov 16 |
1 |
| 4 |
27530256 | Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation. | 2016 Oct |
1 |
| 5 |
25771151 | Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury. | 2015 May |
7 |